Page last updated: 2024-10-30

mechlorethamine and Neurilemmoma

mechlorethamine has been researched along with Neurilemmoma in 2 studies

nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.

Neurilemmoma: A neoplasm that arises from SCHWANN CELLS of the cranial, peripheral, and autonomic nerves. Clinically, these tumors may present as a cranial neuropathy, abdominal or soft tissue mass, intracranial lesion, or with spinal cord compression. Histologically, these tumors are encapsulated, highly vascular, and composed of a homogenous pattern of biphasic fusiform-shaped cells that may have a palisaded appearance. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 5th ed, pp964-5)

Research Excerpts

ExcerptRelevanceReference
"Two cases of malignant schwannoma are reported 13 and 15 years following combined modality treatment for Hodgkin's disease."1.29Malignant schwannoma following treatment for Hodgkin's disease. ( Bridges, LR; Cartwright, SC; Dodwell, DJ; Fisher, PM; Stone, J, 1994)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morbidini-Gaffney, S1
Alpert, TE1
Hatoum, GF1
Sagerman, RH1
Fisher, PM1
Dodwell, DJ1
Bridges, LR1
Cartwright, SC1
Stone, J1

Other Studies

2 other studies available for mechlorethamine and Neurilemmoma

ArticleYear
Benign pleural schwannoma secondary to radiotherapy for Hodgkin disease.
    American journal of clinical oncology, 2005, Volume: 28, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Basal Cell; Combin

2005
Malignant schwannoma following treatment for Hodgkin's disease.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1994, Volume: 6, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Female

1994